The main objective of the study is to determine if there is a difference in the number of
women with a complete miscarriage after 10 days between expectant management versus treatment
with 800 micrograms of misoprostol intravaginally in women with an an incomplete miscarriage
before 14 weeks and a gestational sac retained in the uterus.